Of notice, our study focused on those with CAD who received statin (100%) and underwent PCI, and the results indicated that Lp(a) had pathogenicity in those with both high LDL‐C and hs‐CRP level, but appeared to be less atherogenic in patients whose cholesterol level was well controlled (LDL‐C < 70 mg/dL). The gene discussed is LPA; the disease is coronary artery disorder.